NCT05295056View on ClinicalTrials.gov

Clinical Performance of the AFGen1 Device Over a 7-day Period

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

August 25, 2023

Study Completion Date

August 25, 2023

Conditions
Atrial FibrillationAfibIrregular Heart BeatArrhythmias, CardiacArrhythmia AtrialArrhythmias ParoxysmalParoxysmal Atrial Fibrillation
Interventions
DEVICE

AFGen1 Device Wear Test

Participant wears the device for 7 days

DEVICE

AFGen 1 Device Single Use

Participant wears the device in conjunction with a standard ECG

Trial Locations (1)

63123

Clayton Sleep Institute, St Louis

All Listed Sponsors
lead

TriVirum, Inc.

INDUSTRY